SYSTEMIC RITUXIMAB FOR THE TREATMENT OF THE INDOLENT FORMS OF PRIMARY CUTANEOUS B-CELL LYMPHOMAS: data from the Spanish Primary Cutaneous Lymphoma Registry

Lymphoma
20/07/2020

J Am Acad Dermatol. 2020 Jul 16:S0190-9622(20)32192-7. doi: 10.1016/j.jaad.2020.07.028. Online ahead of print.

NO ABSTRACT